Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.
Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise / Aydin, S. Z.; Direskeneli, H.; Merkel, P. A.; Toloza, S.; Blockmans, D.; Sato, E. I.; De Souza, A. W. S.; Cabral, D.; Carette, S.; Famorca, L.; Khalidi, N.; Milman, N.; Yacyshyn, E.; Tesar, V.; Baslund, B.; Faurschou, M.; Guillevin, L.; Puechal, X.; Aries, P.; Hellmich, B.; Herlyn, K.; Holle, J.; Lamprecht, P.; Moosig, F.; Neumann, T.; Zwerina, J.; Tomasson, G.; Bambery, P.; Jois, R.; Rajasekhar, L.; Sharma, A.; Sivakumar, R.; Molloy, E.; Hashkes, P.; Catapano, F.; Cimino, L.; De Fanti, A.; Pipitone, N.; Salvarani, C.; Vaglio, A.; Kobayashi, S.; Suzuki, K.; Flores-Suarez, L. F.; Hinojosa-Azaola, A.; Brouwer, E.; Rutgers, A.; Stegeman, C.; Suppiah, R.; Hollan, I.; Arguis, P.; Cid, M. C.; Daikeler, T.; Alibaz-Oner, F.; Hamuryudan, V.; Hatemi, G.; Hazirolan, T.; Inanc, M.; Kalayci, M. B.; Kamali, S.; Kansu, T.; Karaaslan, Y.; Karadag, O.; Keser, G.; Onat, A. M.; Ozbalkan, Z.; Ozen, S.; Ozer, H. T. E.; Pamuk, O. N.; Yilmaz, S. G.; Basu, N.; Casian, A.; Chakravarty, K.; D'Cruz, D.; Edelsten, C.; Harper, L.; Jayne, D.; Levy, J.; Mason, J.; Robson, J.; Scott, D.; Stanford, M.; Watts, R.; Albert, D.; Amudala, N.; Beckman, J.; Chacko, B.; Chung, S.; Fessler, B.; Giardino, A.; Grayson, P.; Hunder, G.; Langford, C.; Lerman, M.; Liang, K.; Litt, H.; Mason, T.; Matteson, E.; Mikdashi, J.; Mohler, E.; Monach, P.; Rice, B.; Sharma, A.; Sreih, A.; Stone, J.; Tsapatsaris, N.; Villa-Forte, A.; Warrington, K.; Yazici, Y.; Ytterberg, S.. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 44:12(2017), pp. 1928-1932. [10.3899/jrheum.161269]
Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise
Cimino L.;Salvarani C.;
2017
Abstract
Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
